Cite
HARVARD Citation
Persky, D. et al. (n.d.). A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806. American journal of hematology. 93 (4), pp. 486-493. [Online].